These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25984566)

  • 21. Identification of Pyrazolo[1,5-
    Hu X; Wan B; Liu Y; Shen J; Franzblau SG; Zhang T; Ding K; Lu X
    ACS Med Chem Lett; 2019 Mar; 10(3):295-299. PubMed ID: 30891129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 6-hydrogen-8-methylquinolones active against replicating and non-replicating Mycobacterium tuberculosis.
    Tabarrini O; Sabatini S; Massari S; Pieroni M; Franzblau SG; Cecchetti V
    Chem Biol Drug Des; 2012 Nov; 80(5):781-6. PubMed ID: 22889240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of novel 5-(ethyl or hydroxymethyl) analogs of 2'-'up' fluoro (or hydroxyl) pyrimidine nucleosides as a new class of Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium avium inhibitors.
    Shakya N; Srivastav NC; Bhavanam S; Tse C; Desroches N; Agrawal B; Kunimoto DY; Kumar R
    Bioorg Med Chem; 2012 Jul; 20(13):4088-97. PubMed ID: 22664188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 3'-bromo analogues of pyrimidine nucleosides as a new class of potent inhibitors of Mycobacterium tuberculosis.
    Shakya N; Srivastav NC; Desroches N; Agrawal B; Kunimoto DY; Kumar R
    J Med Chem; 2010 May; 53(10):4130-40. PubMed ID: 20420370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure activity relationships of 4-hydroxy-2-pyridones: A novel class of antituberculosis agents.
    Ng PS; Manjunatha UH; Rao SP; Camacho LR; Ma NL; Herve M; Noble CG; Goh A; Peukert S; Diagana TT; Smith PW; Kondreddi RR
    Eur J Med Chem; 2015 Dec; 106():144-56. PubMed ID: 26544629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antituberculosis agents. VI. Activity of a new ciprofloxacin derivative against Mycobacterium avium and some drug-resistant strains of Mycobacterium tuberculosis.
    Foroumadi A; Soltani F; Moshafi MH
    Boll Chim Farm; 2002; 141(5):394-6. PubMed ID: 12481384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-activity relationships for a series of quinoline-based compounds active against replicating and nonreplicating Mycobacterium tuberculosis.
    Lilienkampf A; Mao J; Wan B; Wang Y; Franzblau SG; Kozikowski AP
    J Med Chem; 2009 Apr; 52(7):2109-18. PubMed ID: 19271749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, antimalarial and antitubercular activities of meridianin derivatives.
    Yadav RR; Khan SI; Singh S; Khan IA; Vishwakarma RA; Bharate SB
    Eur J Med Chem; 2015 Jun; 98():160-9. PubMed ID: 26005918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nitrofuranyl Methyl Piperazines as New Anti-TB Agents: Identification, Validation, Medicinal Chemistry, and PK Studies.
    Yempalla KR; Munagala G; Singh S; Magotra A; Kumar S; Rajput VS; Bharate SS; Tikoo M; Singh GD; Khan IA; Vishwakarma RA; Singh PP
    ACS Med Chem Lett; 2015 Oct; 6(10):1041-6. PubMed ID: 26487909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of antimycobacterial tetrahydrothieno[2,3-c]pyridine-3-carboxamides and hexahydrocycloocta[b]thiophene-3-carboxamides: Molecular modification from known antimycobacterial lead.
    Nallangi R; Samala G; Sridevi JP; Yogeeswari P; Sriram D
    Eur J Med Chem; 2014 Apr; 76():110-7. PubMed ID: 24583350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allylic thiocyanates as a new class of antitubercular agents.
    Silveira GP; Ferreira M; Fernandes L; Moraski GC; Cho S; Hwang C; Franzblau SG; Sá MM
    Bioorg Med Chem Lett; 2012 Oct; 22(20):6486-9. PubMed ID: 22967767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Killing of non-replicating Mycobacterium tuberculosis by 8-hydroxyquinoline.
    Darby CM; Nathan CF
    J Antimicrob Chemother; 2010 Jul; 65(7):1424-7. PubMed ID: 20435781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lead optimization of a novel series of imidazo[1,2-a]pyridine amides leading to a clinical candidate (Q203) as a multi- and extensively-drug-resistant anti-tuberculosis agent.
    Kang S; Kim RY; Seo MJ; Lee S; Kim YM; Seo M; Seo JJ; Ko Y; Choi I; Jang J; Nam J; Park S; Kang H; Kim HJ; Kim J; Ahn S; Pethe K; Nam K; No Z; Kim J
    J Med Chem; 2014 Jun; 57(12):5293-305. PubMed ID: 24870926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 1-Substituted-5-[(3,5-dinitrobenzyl)sulfanyl]-1H-tetrazoles and their isosteric analogs: A new class of selective antitubercular agents active against drug-susceptible and multidrug-resistant mycobacteria.
    Karabanovich G; Roh J; Smutný T; Němeček J; Vicherek P; Stolaříková J; Vejsová M; Dufková I; Vávrová K; Pávek P; Klimešová V; Hrabálek A
    Eur J Med Chem; 2014 Jul; 82():324-40. PubMed ID: 24927053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, biological evaluation, and structure-activity relationships for 5-[(E)-2-arylethenyl]-3-isoxazolecarboxylic acid alkyl ester derivatives as valuable antitubercular chemotypes.
    Pieroni M; Lilienkampf A; Wan B; Wang Y; Franzblau SG; Kozikowski AP
    J Med Chem; 2009 Oct; 52(20):6287-96. PubMed ID: 19757815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and antituberculosis activity of new hydrazide derivatives.
    Kaplancikli ZA; Turan-Zitouni G; Ozdemir A; Teulade JC
    Arch Pharm (Weinheim); 2008 Nov; 341(11):721-4. PubMed ID: 18720343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis, and structure-activity relationship studies of tryptanthrins as antitubercular agents.
    Hwang JM; Oh T; Kaneko T; Upton AM; Franzblau SG; Ma Z; Cho SN; Kim P
    J Nat Prod; 2013 Mar; 76(3):354-67. PubMed ID: 23360475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and evaluation of SQ109 analogues as potential anti-tuberculosis candidates.
    Onajole OK; Govender P; van Helden PD; Kruger HG; Maguire GE; Wiid I; Govender T
    Eur J Med Chem; 2010 May; 45(5):2075-9. PubMed ID: 20149497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.